Back to UBS Group AG UBS Group AG

AGRXAGRX

Showing 0 of 4 quarters

Position history for UBS Group AGUBS Group AG's holdings in AGILE THERAPEUTICS INC

No. UBS Group exited its AGRX (Agile Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 1,387 shares worth $2,705. UBS Group first reported AGRX in Q2 2023 and held it in 2 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

—

No position history available for this security.

Optional analytics helps us improve. How it’s used